Phase 4 HIV and AIDS Trial, Recruiting NCT06158126 Sponsor: University of North Carolina, Chapel Hill Condition: HIV and AIDS
Back to Hiv Aids

Phase 4 HIV and AIDS Trial, Recruiting

NCT06158126
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

(For mothers)

  • A confirmed pregnancy, shown by a urine test or ultrasound
  • Aged 15 years or older
  • Meeting the local Malawi guidelines for PrEP (a type of HIV prevention medication) (confirm with trial site)
  • Testing HIV-negative using the local HIV testing process
  • Testing negative for Hepatitis B (a liver infection)
  • Weighing more than 35 kg
  • Having given informed consent and being willing to take part in study activities alongside their baby

(For babies)

  • Babies enter the study as unborn infants along with their mother — there are no other specific requirements for the baby to be eligible

Who may not be able to join:

(For mothers)

  • People already known to be living with HIV
  • People with known allergies to the study medications (CAB-LA, TDF/3TC, or FTC/TDF)
  • People with another significant illness (current or ongoing), substance use issues, or personal circumstances that the study investigator considers would make participation unsafe
  • People who plan to move away from the Bwaila study area before the scheduled end of their participation in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Friday Saidi, MBBS, MMED, UNC Project Malawi

Phone: 265 88 556 5888

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
17 April 2024
Est. completion
1 December 2026

Where this trial is recruiting

Malawi

Primary endpoints

Rate of composite adverse pregnancy outcomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov